AI assistant
AGRONOMICS LIMITED — Net Asset Value 2015
Jan 12, 2015
7474_rns_2015-01-12_6fca2b58-cdb5-45b0-af15-428b02d5f16a.html
Net Asset Value
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 8934B
Port Erin Biopharma Investments Ltd
12 January 2015
12 January 2015
Port Erin Biopharma Investments Limited
(the "Company")
Net Asset Value calculation to 31 December 2014
Jim Mellon, Chairman, commented: -
"The Net Asset Value ("NAV") calculation for the Company as at closing on 31 December 2014 was 14.29 pence per share, including un-invested cash of £431,744. The portfolio is valued under IFRS at bid price.
Net Assets stand at £4.8 million including Investments of £4.5 million. This quarter's NAV represents a decrease of 1.0% from the previous valuation of 14.42 pence per share, which included un-invested cash of £490,797. On this basis, no additional management fee is due to Shellbay Investments Limited.
Our holding in the Magna Biopharma Income Fund now represents 62% of the portfolio.
We are in the process of finalising a Tender Offer circular, the full details of which will be published later this month."
| Unaudited to 31 December 2014 £ | ||
| Fixed Assets | ||
| Investments | 4,468,412 | |
| Current Assets | ||
| Sundry Debtors | 13,739 | |
| Uninvested cash | 431,744 | |
| Current Liabilities | ||
| Creditors: amounts due | -75,857 | |
| 4,838,038 | ||
| Capital and Reserves | ||
| Share Capital | 34 | |
| Share Premium | 2,759,551 | |
| Current year earnings | -143,388 | |
| Retained earnings | 2,221,841 | |
| 4,838,038 | ||
| Shares in Issue | 33,864,836 | |
| Net Asset Value per share | 14.29 pence | |
--- ENDS ---
Portfolio Details
| Investments as at 31 December 2014 | Value | % of Total Portfolio | |
| Magna Biopharma Income Fund | £2,761,998 | 61.81% | |
| Plethora Solutions Holdings | £561,875 | 12.57% | |
| Summit Corporation | £509,833 | 11.41% | |
| Other quoted holdings | £227,281 | 5.09% | |
| Other unquoted holdings | £407,425 | 9.12% | |
| Total | £4,468,412 | 100.0% | |
For further information, please contact:
| Port Erin Biopharma Investments Limited | Beaumont Cornish Limited | Peterhouse Capital Limited |
| The Company | Nomad | Broker |
| Denham Eke +44 1624 639396 |
Roland Cornish +44 207 628 3396 |
Lucy Williams +44 207 469 0930 |
This information is provided by RNS
The company news service from the London Stock Exchange
END
NAVLIFVALLIFLIE